What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: TechNavio | PRODUCT CODE: 1422544

PUBLISHER: TechNavio | PRODUCT CODE: 1422544

Global Plasma Protease C1 Inhibitor Market 2024-2028

PUBLISHED: January 29, 2024

PAGES: 166 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The plasma protease C1 inhibitor market is forecasted to grow by USD 2.00 bn during 2023-2028, accelerating at a CAGR of 7.55% during the forecast period. The report on the plasma protease C1 inhibitor market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research and development in plasma protease C1 inhibitor, increasing product approvals/launches of plasma protease C1inhibitor, and technological advancements in plasma protease C1 inhibitor.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.12%
CAGR	7.55%
Incremental Value	$2.00bn

Technavio's plasma protease C1 inhibitor market is segmented as below:

By End-user

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Product

Lyophilized
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing adoption of bradykinin B2 receptor antagonist as one of the prime reasons driving the plasma protease C1 inhibitor market growth during the next few years. Also, favorable government initiatives in development and accessibility of plasma protease C1 inhibitor products and introduction of high-quality medical solutions for patients will lead to sizable demand in the market.

The report on the plasma protease C1 inhibitor market covers the following areas:

Plasma protease C1 inhibitor market sizing
Plasma protease C1inhibitor market forecast
Plasma protease C1 inhibitor market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma protease C1 inhibitor market vendors that include AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bio Techne Corp., BioCryst Pharmaceuticals Inc., Biosynth Ltd., Bristol Myers Squibb Co., Cayman Chemical, CSL Ltd., FibroGen Inc., Fresenius SE and Co. KGaA, Gilead Sciences Inc., Ionis Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Merck KGaA, Novartis AG, Pharming Group NV, Sino Biological Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc.. Also, the plasma protease C1 inhibitor market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72978

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global plasma protease C1 inhibitor market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global plasma protease c1 inhibitor market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospital pharmacy - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacy - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacy - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ billion)
Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Lyophilized - Market size and forecast 2023-2028
Exhibit 52: Chart on Lyophilized - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Lyophilized - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Lyophilized - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Lyophilized - Year-over-year growth 2023-2028 (%)
7.4 Injectable - Market size and forecast 2023-2028
Exhibit 56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ billion)
Exhibit 61: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AstraZeneca Plc
Exhibit 111: AstraZeneca Plc - Overview
Exhibit 112: AstraZeneca Plc - Product / Service
Exhibit 113: AstraZeneca Plc - Key news
Exhibit 114: AstraZeneca Plc - Key offerings
12.4 Bausch Health Companies Inc.
Exhibit 115: Bausch Health Companies Inc. - Overview
Exhibit 116: Bausch Health Companies Inc. - Business segments
Exhibit 117: Bausch Health Companies Inc. - Key news
Exhibit 118: Bausch Health Companies Inc. - Key offerings
Exhibit 119: Bausch Health Companies Inc. - Segment focus
12.5 Bio Techne Corp.
Exhibit 120: Bio Techne Corp. - Overview
Exhibit 121: Bio Techne Corp. - Business segments
Exhibit 122: Bio Techne Corp. - Key offerings
Exhibit 123: Bio Techne Corp. - Segment focus
12.6 BioCryst Pharmaceuticals Inc.
Exhibit 124: BioCryst Pharmaceuticals Inc. - Overview
Exhibit 125: BioCryst Pharmaceuticals Inc. - Product / Service
Exhibit 126: BioCryst Pharmaceuticals Inc. - Key offerings
12.7 Biosynth Ltd.
Exhibit 127: Biosynth Ltd. - Overview
Exhibit 128: Biosynth Ltd. - Product / Service
Exhibit 129: Biosynth Ltd. - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 130: Bristol Myers Squibb Co. - Overview
Exhibit 131: Bristol Myers Squibb Co. - Product / Service
Exhibit 132: Bristol Myers Squibb Co. - Key news
Exhibit 133: Bristol Myers Squibb Co. - Key offerings
12.9 Cayman Chemical
Exhibit 134: Cayman Chemical - Overview
Exhibit 135: Cayman Chemical - Product / Service
Exhibit 136: Cayman Chemical - Key offerings
12.10 CSL Ltd.
Exhibit 137: CSL Ltd. - Overview
Exhibit 138: CSL Ltd. - Business segments
Exhibit 139: CSL Ltd. - Key offerings
Exhibit 140: CSL Ltd. - Segment focus
12.11 Fresenius SE and Co. KGaA
Exhibit 141: Fresenius SE and Co. KGaA - Overview
Exhibit 142: Fresenius SE and Co. KGaA - Business segments
Exhibit 143: Fresenius SE and Co. KGaA - Key news
Exhibit 144: Fresenius SE and Co. KGaA - Key offerings
Exhibit 145: Fresenius SE and Co. KGaA - Segment focus
12.12 Ionis Pharmaceuticals Inc.
Exhibit 146: Ionis Pharmaceuticals Inc. - Overview
Exhibit 147: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 148: Ionis Pharmaceuticals Inc. - Key news
Exhibit 149: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 150: Ionis Pharmaceuticals Inc. - Segment focus
12.13 KalVista Pharmaceuticals Inc.
Exhibit 151: KalVista Pharmaceuticals Inc. - Overview
Exhibit 152: KalVista Pharmaceuticals Inc. - Product / Service
Exhibit 153: KalVista Pharmaceuticals Inc. - Key offerings
12.14 Sino Biological Inc.
Exhibit 154: Sino Biological Inc. - Overview
Exhibit 155: Sino Biological Inc. - Product / Service
Exhibit 156: Sino Biological Inc. - Key offerings
12.15 Takeda Pharmaceutical Co. Ltd.
Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 161: Thermo Fisher Scientific Inc. - Overview
Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
Exhibit 163: Thermo Fisher Scientific Inc. - Key news
Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus
12.17 Vertex Pharmaceuticals Inc.
Exhibit 166: Vertex Pharmaceuticals Inc. - Overview
Exhibit 167: Vertex Pharmaceuticals Inc. - Product / Service
Exhibit 168: Vertex Pharmaceuticals Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations

Product Code: IRTNTR72978

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global plasma protease c1 inhibitor market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Product - Market share 2023-2028 (%)
Exhibits49: Data Table on Product - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Lyophilized - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Lyophilized - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Lyophilized - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Lyophilized - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Product ($ billion)
Exhibits61: Data Table on Market opportunity by Product ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AstraZeneca Plc - Overview
Exhibits112: AstraZeneca Plc - Product / Service
Exhibits113: AstraZeneca Plc - Key news
Exhibits114: AstraZeneca Plc - Key offerings
Exhibits115: Bausch Health Companies Inc. - Overview
Exhibits116: Bausch Health Companies Inc. - Business segments
Exhibits117: Bausch Health Companies Inc. - Key news
Exhibits118: Bausch Health Companies Inc. - Key offerings
Exhibits119: Bausch Health Companies Inc. - Segment focus
Exhibits120: Bio Techne Corp. - Overview
Exhibits121: Bio Techne Corp. - Business segments
Exhibits122: Bio Techne Corp. - Key offerings
Exhibits123: Bio Techne Corp. - Segment focus
Exhibits124: BioCryst Pharmaceuticals Inc. - Overview
Exhibits125: BioCryst Pharmaceuticals Inc. - Product / Service
Exhibits126: BioCryst Pharmaceuticals Inc. - Key offerings
Exhibits127: Biosynth Ltd. - Overview
Exhibits128: Biosynth Ltd. - Product / Service
Exhibits129: Biosynth Ltd. - Key offerings
Exhibits130: Bristol Myers Squibb Co. - Overview
Exhibits131: Bristol Myers Squibb Co. - Product / Service
Exhibits132: Bristol Myers Squibb Co. - Key news
Exhibits133: Bristol Myers Squibb Co. - Key offerings
Exhibits134: Cayman Chemical - Overview
Exhibits135: Cayman Chemical - Product / Service
Exhibits136: Cayman Chemical - Key offerings
Exhibits137: CSL Ltd. - Overview
Exhibits138: CSL Ltd. - Business segments
Exhibits139: CSL Ltd. - Key offerings
Exhibits140: CSL Ltd. - Segment focus
Exhibits141: Fresenius SE and Co. KGaA - Overview
Exhibits142: Fresenius SE and Co. KGaA - Business segments
Exhibits143: Fresenius SE and Co. KGaA - Key news
Exhibits144: Fresenius SE and Co. KGaA - Key offerings
Exhibits145: Fresenius SE and Co. KGaA - Segment focus
Exhibits146: Ionis Pharmaceuticals Inc. - Overview
Exhibits147: Ionis Pharmaceuticals Inc. - Business segments
Exhibits148: Ionis Pharmaceuticals Inc. - Key news
Exhibits149: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits150: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits151: KalVista Pharmaceuticals Inc. - Overview
Exhibits152: KalVista Pharmaceuticals Inc. - Product / Service
Exhibits153: KalVista Pharmaceuticals Inc. - Key offerings
Exhibits154: Sino Biological Inc. - Overview
Exhibits155: Sino Biological Inc. - Product / Service
Exhibits156: Sino Biological Inc. - Key offerings
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits161: Thermo Fisher Scientific Inc. - Overview
Exhibits162: Thermo Fisher Scientific Inc. - Business segments
Exhibits163: Thermo Fisher Scientific Inc. - Key news
Exhibits164: Thermo Fisher Scientific Inc. - Key offerings
Exhibits165: Thermo Fisher Scientific Inc. - Segment focus
Exhibits166: Vertex Pharmaceuticals Inc. - Overview
Exhibits167: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits168: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations